1. Home
  2. WST vs TROW Comparison

WST vs TROW Comparison

Compare WST & TROW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WST
  • TROW
  • Stock Information
  • Founded
  • WST 1923
  • TROW 1937
  • Country
  • WST United States
  • TROW United States
  • Employees
  • WST N/A
  • TROW N/A
  • Industry
  • WST Medical/Dental Instruments
  • TROW Investment Bankers/Brokers/Service
  • Sector
  • WST Health Care
  • TROW Finance
  • Exchange
  • WST Nasdaq
  • TROW Nasdaq
  • Market Cap
  • WST 15.6B
  • TROW 19.7B
  • IPO Year
  • WST N/A
  • TROW N/A
  • Fundamental
  • Price
  • WST $216.71
  • TROW $96.21
  • Analyst Decision
  • WST Buy
  • TROW Sell
  • Analyst Count
  • WST 7
  • TROW 12
  • Target Price
  • WST $331.67
  • TROW $95.92
  • AVG Volume (30 Days)
  • WST 690.0K
  • TROW 1.3M
  • Earning Date
  • WST 07-24-2025
  • TROW 07-25-2025
  • Dividend Yield
  • WST 0.38%
  • TROW 5.26%
  • EPS Growth
  • WST N/A
  • TROW 4.63
  • EPS
  • WST 6.37
  • TROW 8.81
  • Revenue
  • WST $2,895,800,000.00
  • TROW $7,107,300,000.00
  • Revenue This Year
  • WST $3.38
  • TROW $0.12
  • Revenue Next Year
  • WST $5.85
  • TROW $2.56
  • P/E Ratio
  • WST $34.31
  • TROW $10.96
  • Revenue Growth
  • WST N/A
  • TROW 6.51
  • 52 Week Low
  • WST $187.43
  • TROW $77.85
  • 52 Week High
  • WST $352.33
  • TROW $125.81
  • Technical
  • Relative Strength Index (RSI)
  • WST 48.20
  • TROW 58.08
  • Support Level
  • WST $215.67
  • TROW $94.27
  • Resistance Level
  • WST $223.77
  • TROW $95.53
  • Average True Range (ATR)
  • WST 4.99
  • TROW 1.55
  • MACD
  • WST -0.52
  • TROW 0.17
  • Stochastic Oscillator
  • WST 19.10
  • TROW 95.43

About WST West Pharmaceutical Services Inc.

West Pharmaceutical Services is based in Pennsylvania, US, and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), non-glass containment solutions, and auto-injectors for injectable drugs, which include large molecule biologics, peptides such as GLP-1 receptor agonists, and small molecule drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.

About TROW T. Rowe Price Group Inc.

T. Rowe Price provides asset-management services for individual and institutional investors. It offers a broad range of no-load us and international stock, hybrid, bond, and money market funds. At the end of October 2024, the firm had $1.607 trillion in managed assets, composed of equity (51%), balanced (34%), fixed-income and money market (12%), and alternative (3%) offerings. Approximately two thirds of managed assets are held in retirement-based accounts, which provides T. Rowe Price with a somewhat stickier client base than most of its peers. The firm also manages private accounts, provides retirement planning advice, and offers discount brokerage and trust services. The company is primarily a us-based asset manager, deriving less than 10% of its AUM from overseas.

Share on Social Networks: